PEP lecture
... unprotected sex by 80% during month of treatment – Most patients reported being high on alcohol or drugs or both when had unprotected sex ...
... unprotected sex by 80% during month of treatment – Most patients reported being high on alcohol or drugs or both when had unprotected sex ...
publications list
... PSA, Jereza LD, Emphasis YEE, Prasetyo AA, Tanimoto T, and Ichimura H. Tracking the Entry Routes of Hepatitis C Virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines. J Med Virol, ...
... PSA, Jereza LD, Emphasis YEE, Prasetyo AA, Tanimoto T, and Ichimura H. Tracking the Entry Routes of Hepatitis C Virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines. J Med Virol, ...
Communicable Disease
... Some communicable diseases may not be infectious BUT all infectious diseases are communicable. communicable but not infectious: -tetanus - botulism - staphylococcal food poisoning INCUBATION PERIOD - time interval between initial contact with an infectious agent and the first appearance of sympto ...
... Some communicable diseases may not be infectious BUT all infectious diseases are communicable. communicable but not infectious: -tetanus - botulism - staphylococcal food poisoning INCUBATION PERIOD - time interval between initial contact with an infectious agent and the first appearance of sympto ...
Determination of Effective Elution Buffers for Extracting Viral RNA
... coupon cut from a Kimberly Clark 47080 Procedure Mask. 10 coupons were suspended separately in 2mL of each of the stock solutions. 10 Coupons were also suspended separately in the predetermined MHBSS. Therefore there were 120 coupons tested. The coupons were allowed to elute overnight. Following elu ...
... coupon cut from a Kimberly Clark 47080 Procedure Mask. 10 coupons were suspended separately in 2mL of each of the stock solutions. 10 Coupons were also suspended separately in the predetermined MHBSS. Therefore there were 120 coupons tested. The coupons were allowed to elute overnight. Following elu ...
Transmission of Hepatitis C Virus: Rates, Routes
... with HCV infection. The assessment of HCV transmission has been complicated by the rapid pace of change in diagnostic methods. The serologic diagnosis of HCV has evolved considerably since antibody tests were first made available in 1990. Second generation immunosorbent assay (enzyme immunoassay (EI ...
... with HCV infection. The assessment of HCV transmission has been complicated by the rapid pace of change in diagnostic methods. The serologic diagnosis of HCV has evolved considerably since antibody tests were first made available in 1990. Second generation immunosorbent assay (enzyme immunoassay (EI ...
MATERIAL SAFETY DATA SHEET
... techniques are rarely employed for diagnostic purposes in epidemiological studies. Rapid diagnostic techniques for viral antigen detection, including immunofluorescent-antibody assay, optical immunoassay, enzyme immunoassay, and chromatographic immunoassay are preferred. Most are commercially availa ...
... techniques are rarely employed for diagnostic purposes in epidemiological studies. Rapid diagnostic techniques for viral antigen detection, including immunofluorescent-antibody assay, optical immunoassay, enzyme immunoassay, and chromatographic immunoassay are preferred. Most are commercially availa ...
Coinfection with Hepatitis C Virus among HIV-1
... HIV-1 and HCV share similar modes of transmission. Comparable to transmission of human immunodeficiency virus type 1 (HIV-1), HCV can be transmitted via sexual contact as well as by mother to child vertical transmission. In addition, intravenous drug use (IVDU) also plays a significant role in trans ...
... HIV-1 and HCV share similar modes of transmission. Comparable to transmission of human immunodeficiency virus type 1 (HIV-1), HCV can be transmitted via sexual contact as well as by mother to child vertical transmission. In addition, intravenous drug use (IVDU) also plays a significant role in trans ...
urinary tract infection - University of Virginia
... PAIN RELIEVERS such as ibuprofen or acetaminophen may help bladder discomfort. Your physician or nurse practitioner may recommend a urinary pain reliever if you have a lot of pain when you urinate. In addition, urinary analgesics that contain phenazopyridine (brands A20-Gesic, A20-standard, others) ...
... PAIN RELIEVERS such as ibuprofen or acetaminophen may help bladder discomfort. Your physician or nurse practitioner may recommend a urinary pain reliever if you have a lot of pain when you urinate. In addition, urinary analgesics that contain phenazopyridine (brands A20-Gesic, A20-standard, others) ...
Cytokine and Chemokine Gene Expression after Primary and
... American Type Culture Collection. Virus stock was prepared in HEp-2 cells and contained 106 pfu/mL. Virus titers in the stocks and in the organ homogenates were determined by plaque assay ...
... American Type Culture Collection. Virus stock was prepared in HEp-2 cells and contained 106 pfu/mL. Virus titers in the stocks and in the organ homogenates were determined by plaque assay ...
Infections and Infestations Dr Iain Henderson GP Scotstoun Hospital Practitioner, Western Infirmary
... • Staph and Strep are the most likely organisms • Eczema doesn’t have to look that bad to be infected • Swabs very useful • Can see if Fucidic Acid resistance • Eczema sufferers have a higher rate of carriage of staph ...
... • Staph and Strep are the most likely organisms • Eczema doesn’t have to look that bad to be infected • Swabs very useful • Can see if Fucidic Acid resistance • Eczema sufferers have a higher rate of carriage of staph ...
YMDD Mutations and Genotypes of Hepatitis B Virus in Northern
... treatment. Recently we found that 2 patients, who were not included in this study, had shifted to the mixed type (YIDD and YVDD) (unpublished observation), indicating that the shift can occur over a relatively long period. During the past few years, many researchers have investigated the forecasting ...
... treatment. Recently we found that 2 patients, who were not included in this study, had shifted to the mixed type (YIDD and YVDD) (unpublished observation), indicating that the shift can occur over a relatively long period. During the past few years, many researchers have investigated the forecasting ...
Information for staff on Aspergillus spp.
... recommended for patients at high risk of developing invasive aspergillosis, e.g. HSCT recipients with graft-versus host disease (GVHD) and neutropenic patients with acute myelogenous leukaemia (AML) or myelodysplastic syndrome (MDS).1;2 Highly immunosuppressed patients should be managed in a HEPA-fi ...
... recommended for patients at high risk of developing invasive aspergillosis, e.g. HSCT recipients with graft-versus host disease (GVHD) and neutropenic patients with acute myelogenous leukaemia (AML) or myelodysplastic syndrome (MDS).1;2 Highly immunosuppressed patients should be managed in a HEPA-fi ...
Infectious-Disease-Exclusion-Periods
... Parents are asked to adhere strictly to the following instructions. These have been prepared following advice sent out by other schools and with reference to Lothian Health Board’s Health Protection Team. Children should also be kept at home if they are not fully fit. Disease/Illness ...
... Parents are asked to adhere strictly to the following instructions. These have been prepared following advice sent out by other schools and with reference to Lothian Health Board’s Health Protection Team. Children should also be kept at home if they are not fully fit. Disease/Illness ...
Antiviral Medication Use and Cost of Hepatitis Infected Diseases
... incidence of cirrhosis and liver cancer [1]. In the 1990s, lamivudine was released to the domestic market as the first nucleoside treatment for chronic hepatitis B. However, long-term lamivudine use is associated with viral gene mutations. As time on the medication increases, the proportion of patie ...
... incidence of cirrhosis and liver cancer [1]. In the 1990s, lamivudine was released to the domestic market as the first nucleoside treatment for chronic hepatitis B. However, long-term lamivudine use is associated with viral gene mutations. As time on the medication increases, the proportion of patie ...
Document
... [COPD] and cystic fibrosis) • Heart disease (such as congenital heart disease, congestive heart failure and coronary artery disease) • Blood disorders (such as sickle cell disease) • Endocrine disorders (such as diabetes mellitus) • Kidney disorders • Liver disorders • Metabolic disorders (such as i ...
... [COPD] and cystic fibrosis) • Heart disease (such as congenital heart disease, congestive heart failure and coronary artery disease) • Blood disorders (such as sickle cell disease) • Endocrine disorders (such as diabetes mellitus) • Kidney disorders • Liver disorders • Metabolic disorders (such as i ...
Chapter 9: Health system response: Infection Control
... Duration of shedding is likely to be shorter with the use of antivirals. There is very limited information on transmission of infection in those who are in the incubation period of the disease. In a recent review article, the WHO writing group identified only one published report in which transmissi ...
... Duration of shedding is likely to be shorter with the use of antivirals. There is very limited information on transmission of infection in those who are in the incubation period of the disease. In a recent review article, the WHO writing group identified only one published report in which transmissi ...
BIOLOGICAL AGENTS
... The course of the disease is very much like that of Leptospirosis (see later), but is usually much less severe and normally self-limiting, with recovery in about six weeks. In about 5% of cases chronic infectious Hepatitis follows, leading to cirrhosis, liver cancer and possibly death. Some individu ...
... The course of the disease is very much like that of Leptospirosis (see later), but is usually much less severe and normally self-limiting, with recovery in about six weeks. In about 5% of cases chronic infectious Hepatitis follows, leading to cirrhosis, liver cancer and possibly death. Some individu ...
Infection_Prevention_and_Control
... mask before entering the room; if seal is NOT obtained, the room should NOT be entered Signs/Symptoms of TB can appear months or years after initial exposure ...
... mask before entering the room; if seal is NOT obtained, the room should NOT be entered Signs/Symptoms of TB can appear months or years after initial exposure ...
Section 5 Sexually Transmitted Infections and Bloodborne Pathogens
... Reservoir: Individuals who are asymptomatic, particularly untreated infected males continue to serve as a large reservoir capable of transmitting C. trachomatis to sexual partners. C. trachomatis grows in the vagina and/or urethra of infected persons. It may be found in the rectum and/or throat as w ...
... Reservoir: Individuals who are asymptomatic, particularly untreated infected males continue to serve as a large reservoir capable of transmitting C. trachomatis to sexual partners. C. trachomatis grows in the vagina and/or urethra of infected persons. It may be found in the rectum and/or throat as w ...
Human Immunodeficiency Virus (HIV)
... people infected with HIV worldwide, including over 1 million people in the United States. Almost a quarter of the people in the U.S. that are infected with HIV are unaware of their infection, posing a high risk of further spreading the virus. HIV affects everyone in the U.S., but the impact has been ...
... people infected with HIV worldwide, including over 1 million people in the United States. Almost a quarter of the people in the U.S. that are infected with HIV are unaware of their infection, posing a high risk of further spreading the virus. HIV affects everyone in the U.S., but the impact has been ...
Return of the giant zombie virus
... body’s immune system, greatly lowering resistance to infections and some cancers. It is caused by the HIV germ. (See also HIV) amoeba ...
... body’s immune system, greatly lowering resistance to infections and some cancers. It is caused by the HIV germ. (See also HIV) amoeba ...
ICE Handout final
... There is no vaccine for HCV The virus can live in body 20 to 30 years A small number of people with hepatitis C infection may develop liver cancer Liver failure may occurs as a result of severe damaged by hepatitis C Monitoring the Condition of The Liver ...
... There is no vaccine for HCV The virus can live in body 20 to 30 years A small number of people with hepatitis C infection may develop liver cancer Liver failure may occurs as a result of severe damaged by hepatitis C Monitoring the Condition of The Liver ...
Sinusitis Arrhythmia Infection
... connected to the inhalation and exhalation process, respiration. When a person has severe congestion and is not breathing well, the sinus rhythm can be disrupted. The person may experience their heart “flutter”. Arrhythmia is a syndrome which takes place when there is interference in the sinus node, ...
... connected to the inhalation and exhalation process, respiration. When a person has severe congestion and is not breathing well, the sinus rhythm can be disrupted. The person may experience their heart “flutter”. Arrhythmia is a syndrome which takes place when there is interference in the sinus node, ...
Hepatitis C
Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure, liver cancer, or life-threatening esophageal and gastric varices.HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, and transfusions. An estimated 150–200 million people worldwide are infected with hepatitis C. The existence of hepatitis C – originally identifiable only as a type of non-A non-B hepatitis – was suggested in the 1970s and proven in 1989. Hepatitis C infects only humans and chimpanzees. It is one of five known hepatitis viruses: A, B, C, D, and E.The virus persists in the liver in about 85% of those infected. This chronic infection can be treated with medication: the standard therapy is a combination of peginterferon and ribavirin, with either boceprevir or telaprevir added in some cases. Overall, 50–80% of people treated are cured. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation. No vaccine against hepatitis C is available. About 343,000 deaths due to liver cancer from hepatitis C occurred in 2013, up from 198,000 in 1990. An additional 358,000 in 2013 occurred due to cirrhosis.